Bristol-Myers Squibb Announces Dividend

Thu Mar 7, 2013 5:49pm EST

* Reuters is not responsible for the content in this press release.

http://pdf.reuters.com/htmlnews/8knews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20130307:nBw076494a

NEW YORK--(Business Wire)--
The Board of Directors of Bristol-Myers Squibb Company (NYSE:BMY) today declared
a quarterly dividend of thirty-five cents ($0.35) per share on the $0.10 par
value Common Stock of the corporation. The quarterly dividend will be payable on
May 1, 2013, to stockholders of record at the close of business on April 5,
2013. 

The Directors also declared a quarterly dividend of fifty cents ($0.50) per
share on the $2.00 Convertible Preferred Stock of the corporation, payable June
3, 2013, to stockholders of record at the close of business on May 10, 2013. 

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to
discover, develop and deliver innovative medicines that help patients prevail
over serious diseases. For more information, please visit www.bms.com or follow
us on Twitter at http://twitter.com/bmsnews.

Bristol-Myers Squibb
Media:
Jennifer Fron Mauer, 609-252-6579
jennifer.mauer@bms.com
or
Investors:
John Elicker, 609-252-4611
john.elicker@bms.com



Copyright Business Wire 2013

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.